Literature DB >> 2310424

Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.

K Suzaki1, S Kobori, S Ueno, M Uehara, T Kayashima, H Takeda, S Fukuda, K Takahashi, N Nakamura, H Uzawa.   

Abstract

A 59-year-old woman, one of 5 cases with familial type III hyperlipoproteinemia reported at our clinic to date, had nephrotic syndrome and diabetes mellitus, but had neither coronary atherosclerosis nor xanthoma. A renal biopsy specimen revealed a massive cluster of foam cells containing apolipoprotein B and E in the mesangial region of the kidney. A restricted diet intake combined with lipid-lowering drugs such as cholestyramine, clinofibrate, and bezafibrate, in addition to methylprednisolone was not very effective in lowering serum triglyceride and cholesterol levels within physiological ranges. Therefore, plasmapheresis, using a dextran sulfate-cellulose column, was performed. Repeated plasmapheresis resulted in a marked decrease in both serum total cholesterol and triglyceride. A second renal biopsy specimen performed 2 years later revealed a marked reduction in foam cells with concurrent improvement in her nephrotic syndrome and glucose intolerance. These results suggest that familial type III hyperlipoproteinemia may be responsible for glomerular lipidosis resulting in nephrotic syndrome. They also indicate that plasmapheresis using a dextran sulfate-cellulose column is very effective in the removal of abnormal lipoproteins such as beta-very low density lipoprotein and intermediate density lipoprotein in a case of familial type III hyperlipoproteinemia.

Entities:  

Mesh:

Year:  1990        PMID: 2310424     DOI: 10.1016/0021-9150(90)90025-e

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Pathology of glomerular lipidosis.

Authors:  Hiroshi Sato; Nobuyuki Takahashi; Emiko Sato; Kiyomi Kisu; Sadayoshi Ito; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

Review 2.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 3.  Systemic and renal lipids in kidney disease development and progression.

Authors:  Patricia Wahl; Gloria Michelle Ducasa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

4.  The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.

Authors:  G Feussner; M Eichinger; R Ziegler
Journal:  Clin Investig       Date:  1992-11

Review 5.  Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.

Authors:  Miho Karube; Kimimasa Nakabayashi; Yasunori Fujioka; Ken Yoshihara; Akira Yamada; Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

6.  Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis.

Authors:  G Feussner; S Wey; J Bommer; D Deppermann; P Grützmacher; R Ziegler
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

7.  Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.

Authors:  Rachel A Davey; Niall C Tebbutt; Jenny M Favaloro; David N O'neal; Derek Rae; Jeffrey D Zajac; James D Best
Journal:  Lipids Health Dis       Date:  2006-12-17       Impact factor: 3.876

8.  A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka.

Authors:  Hisako Hirashima; Toshiyuki Komiya; Naoya Toriu; Shigeo Hara; Akira Matsunaga; Takao Saito; Eri Muso
Journal:  Clin Nephrol Case Stud       Date:  2018-11-30

9.  Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.

Authors:  Kunio Kawanishi; Anri Sawada; Ayami Ochi; Takahito Moriyama; Michihiro Mitobe; Toshio Mochizuki; Kazuho Honda; Hideaki Oda; Toshio Nishikawa; Kosaku Nitta
Journal:  Case Rep Nephrol Urol       Date:  2013-11-28

10.  Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.

Authors:  Satoshi Takasaki; Kunihiko Maeda; Kensuke Joh; Shu Yamakage; Sachiko Fukase; Toshiyuki Takahashi; Masayuki Suzuki; Akira Matsunaga; Takao Saito
Journal:  Case Rep Nephrol Dial       Date:  2015-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.